NEW YORK (GenomeWeb) – NanoString Technologies preannounced its fourth quarter and full-year 2014 revenues after the close of the market on Thursday.

For the fourth quarter, the Seattle-based firm said that revenues are anticipated to be in the range of $15 million to $16 million, which would represent an increase of 48 percent to 58 percent year over year from $10.1 million in revenues during Q4 2013. The consensus analyst estimate for revenues in the quarter is $15 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.